Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

January 17, 2021
Preprint
Open Access

Phospholipids Uniquely Modify Secondary Structure of α-Synuclein Oligomers

BioRxiv : the Preprint Server for Biology
T. DouDmitry Kurouski
January 8, 2021
Review
Open Access

Alpha-Synuclein Antibody Characterization: Why Semantics Matters

Molecular Neurobiology
Tiago Fleming Outeiro
January 17, 2021

Interplay between tau and α-synuclein LLPS

Protein Science : a Publication of the Protein Society
Anna SiegertMarkus Zweckstetter
January 3, 2021
Open Access

Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies

Journal of Molecular Cell Biology
Maarten C HardenbergMichele Vendruscolo
December 23, 2020

Acceleration of α-synuclein fibril formation and associated cytotoxicity stimulated by silica nanoparticles as a model of neurodegenerative diseases

International Journal of Biological Macromolecules
Chao PangMojtaba Falahati
January 3, 2021
Preprint
Open Access

Distinct cryo-EM Structure of α-synuclein Filaments derived by Tau

BioRxiv : the Preprint Server for Biology
A. HojjatianKwang Hun Lim
December 30, 2020
Review
Open Access

Exosomes in Parkinson Disease

Journal of Neurochemistry
Jennifer R PinnellKim Tieu
December 22, 2020
Review

Role of RhoA-ROCK signaling in Parkinson's disease

European Journal of Pharmacology
Mahalaxmi IyerBalachandar Vellingiri
December 29, 2020
Open Access

11 C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates

European Journal of Nuclear Medicine and Molecular Imaging
Laura KueblerKristina Herfert
December 19, 2020

Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide

Chemistry and Physics of Lipids
Dipita Bhattacharyya, Anirban Bhunia
December 24, 2020
Preprint
Open Access

Overexpression of human alpha-synuclein leads to dysregulated microbiome and metabolites with ageing in a rat model of Parkinson disease

BioRxiv : the Preprint Server for Biology
Yogesh SinghN. Casadei
January 12, 2021
Open Access

Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo

Neurobiology of Disease
Antonio Dominguez-MeijideTiago Fleming Outeiro
January 17, 2021
Open Access

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease

International Journal of Molecular Sciences
Laura Marsal-GarcíaKatrin Beyer
January 9, 2021

Distinguishing normal and aggregated alpha-synuclein interaction on gold nanorod incorporated zinc oxide nanocomposite by electrochemical technique

International Journal of Biological Macromolecules
Hussaini AdamUda Hashim
December 22, 2020

Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease

Nutritional Neuroscience
Elvis CuevasSumit Sarkar
December 18, 2020
Review
Open Access

Extracellular Vesicles Loaded miRNAs as Potential Modulators Shared Between Glioblastoma, and Parkinson's and Alzheimer's Diseases

Frontiers in Cellular Neuroscience
Laura ThomasCarolina Perez-Castro

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/alpha-synuclein-aggregation/cb325b50-e1da-42be-a718-5beab88d57dc